Glioblastoma Response Prediction to Apatinib
Clinical trial NCT04814329 · COMPLETED
Trial details
- NCT number
- NCT04814329
- Sponsor
- Beijing Sanbo Brain Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.